Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ligand Pharmaceuticals Incorporated (LGND)

  • Company Report
  • Aug. 09, 2022, 13:59 UTC
  • 63
  • 0 comments

New SEC Form for Ligand Pharmaceuticals Incorporated

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Aug. 09, 2022, 13:51 UTC
  • 66
  • 0 comments

New SEC Filing for (CIK:0001061027)

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Aug. 09, 2022, 13:50 UTC
  • 66
  • 0 comments

New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX)

Comment Full text

MannKind Corporation (MNKD)

  • Company Report
  • Aug. 09, 2022, 13:48 UTC
  • 71
  • 0 comments

New Form 10-Q for MannKind Corporation

Comment Full text

Neoleukin Therapeutics Inc. (NLTX)

  • Company Report
  • Aug. 09, 2022, 13:42 UTC
  • 72
  • 0 comments

New Form 10-Q for Neoleukin Therapeutics, Inc.

Comment Full text

Halozyme Therapeutics Inc. (HALO)

  • Company Report
  • Aug. 09, 2022, 13:03 UTC
  • 66
  • 0 comments

Halozyme - Second Quarter 2022

Comment Full text

Avidity Biosciences Inc (RNA)

  • Company Report
  • Aug. 09, 2022, 10:35 UTC
  • 66
  • 0 comments

New SEC Filing for Avidity Biosciences Inc. (NASDAQ:RNA)

Comment Full text

Relmada Therapeutics Inc. (RLMD)

  • Company Report
  • Aug. 09, 2022, 06:46 UTC
  • 65
  • 0 comments

Relmada Therapeutics Receives FDA Fast Track Designation for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Aug. 09, 2022, 05:50 UTC
  • 71
  • 0 comments

New SEC Filing for Viracta Therapeutics Inc. (NASDAQ:VIRX)

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Company Report
  • Aug. 09, 2022, 05:50 UTC
  • 69
  • 0 comments

New SEC Filing for (CIK:0001061027)

Comment Full text
  • Previous
  • 63
  • 64
  • 65
  • 66
  • 67
  • Next

Search

News categories

  • Technical Exchange News(10587)
  • Event(1974)
  • SEC News(184242)
  • FDA Approval(9830)
  • Company Report(721)
  • Business News(122131)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin